NVision Imaging Raises $55M Series B

NVision Imaging raised $55M in a Series B round announced on May 13, 2026. Developer of MRI polarizers and hyperpolarized imaging agents.

Round size
$55M
Stage
Series B
Headquarters
Germany
Announced
May 13, 2026

The company

Developer of MRI polarizers and hyperpolarized imaging agents.

The funding

NVision Imaging, based in Ulm, Germany, announced $55M in Series B financing on May 13, 2026.

Participants include European Investment Bank, Entrée Capital, Playground Global, Abbott, Matterwave / b2ventures.

Where the funding goes

    Sources

    1. Tech.eu Funding Explorer
    03 / Related rounds

    Related funding rounds

    01
    Series B · Healthtech

    Isomorphic Labs

    UK-based AI-first drug design and development company.

    Led by Thrive Capital
    $2.1B
    02
    Series B · AI

    Fractile

    Fractile designs and builds AI compute systems and processors for frontier model inference.

    $220M
    03
    Series B · Deeptech

    QuantWare

    QuantWare engages in designing, developing, and fabricating hardware to enable quantum computing.

    €152M